Active, Not Recruiting
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
NCT05873205
- Conditions
- Blood Cancer, Hematologic Diseases, Hematologic Neoplasms, +4 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) Commack, New York, United States